Schonfeld Strategic Advisors LLC Athenex, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.12 - $0.21 $71,895 - $125,816	-599,126 Reduced 50.68%	583,000 $87,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $256,350 - $1.19 Million	1,068,126 Added 936.95%	1,182,126 $319,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $41 - $91	-100 Reduced 0.09%	114,000 $46,000
Q1 2022 May 16, 2022	BUY	$0.79 - $1.59 $90,139 - $181,419	114,100 New	114,100 $95,000
Q3 2021 Nov 16, 2021	SELL	$2.97 - $4.84 $189,836 - $309,363	-63,918 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $475,213 - $657,101	-128,090 Reduced 66.71%	63,918 $295,000
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $460,020 - $1.66 Million	-112,750 Reduced 37.0%	192,008 $826,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $6.29 Million - $7.97 Million	-568,898 Reduced 65.12%	304,758 $3.37 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $6.95 Million - $9.86 Million	677,422 Added 345.21%	873,656 $11,000
Q2 2020 Aug 14, 2020	BUY	$7.11 - $13.76 $464,254 - $898,472	65,296 Added 49.87%	196,234 $2.7 Million
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $4.02 Million - $11.2 Million	-703,573 Reduced 84.31%	130,938 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $2.19 Million - $4.06 Million	228,511 Added 37.71%	834,511 $12.7 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $2.36 Million - $4.08 Million	194,200 Added 47.16%	606,000 $7.37 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $1.31 Million - $2.74 Million	138,300 Added 50.57%	411,800 $8.15 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $13.49 $1.87 Million - $2.26 Million	167,900 Added 159.0%	273,500 $3.35 Million
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $829,440 - $1.25 Million	81,000 Added 329.27%	105,600 $1.34 Million
Q3 2018 Nov 14, 2018	BUY	$15.53 - $19.97 $382,038 - $491,262	24,600 New	24,600 $382,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account